Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
NCT07057011
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Premature Ejaculation
Interventions
DRUG:
Paroxetine 20 Mg Oral Tablet
Sponsor
South Valley University